← All diseases Cancer

Lung cancer (non-small cell)

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchHighest level evidence only (185)Meta-analysis (67)Treatment guideline (1)Randomized trial (51)Systematic review (38)Phase 3 study (28)Clinical trial (665)Review article (246)Early study (phase 1 or 2) (63)Case report (126)Laboratory or animal research (69)Commentary or Editorial (86)Retracted publication (14) Studies currently recruiting participants only (62)

Filter

Publications and studies (3220)

• Value of serum CEA and CA19-9 dynamic changes and trajectory modeling in prognosis assessment for non-small cell lung cancer. (2026/07/27) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Fatal osimertinib-related interstitial lung disease during adjuvant therapy after left pneumonectomy in a patient with lung adenocarcinoma undergoing maintenance hemodialysis. (2026/07/27) ♡
• Cost-effectiveness analysis of sacituzumab tirumotecan vs. chemotherapy for patients with EGFR-TKI-resistant, EGFR-mutated advanced non-small cell lung cancer in China. (2026/07/27) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. CT-derived topological intratumoral heterogeneity predicts major pathological response to neoadjuvant immunochemotherapy in resectable non-small-cell lung cancer: a two-center study. (2026/07/27) ♡
• Immunological biomarkers for precision stereotactic body radiation therapy in early-stage non-small cell lung cancer: a systematic review. (2026/07/24) ♡
• A novel multivariate framework for functional gene networks enrichment analysis. (2026/07/24) ♡
• A novel photosensitizer (hE26) for photodynamic therapy enhances anticancer efficacy via reactive oxygen species-induced mitochondrial apoptosis in non-small cell lung cancer. (2026/07/24) ♡
• Transitioning from multiport to uniport robot-assisted thoracic surgery: a propensity score-weighted evaluation of safety and feasibility. (2026/07/24) ♡
• Functional restoration of conformational (R175H) and contact (R273H) mutant p53 by Bacillus-derived Hydroxymycotrienin A in non-small cell lung cancer: a computational approach. (2026/07/24) ♡
• Genetic landscape features associated with PD-L1 expression status in advanced lung adenocarcinoma: a targeted sequencing analysis. (2026/07/23) ♡
• Cost-effectiveness analysis of combined immunotherapy regimens for non-squamous non-small lung cancer after tyrosine kinase inhibitors resistance. (2026/07/23) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Editorial: Liquid biopsy in non-small cell lung cancer for diagnosis, treatment selection and monitoring. (2026/07/23) ♡
• Oncolytic adenovirus armed with cGAS activates STING pathway and enhances antitumor immunity in lung cancer with superior combined efficacy of PD-L1 therapy. (2026/07/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Microbiome as a prediction of immunotherapy response in lung cancer. (2026/07/23) ♡
• Integrated cellular, proteomic and metabolomic profiling of immune-related adverse events in non-small cell lung cancer. (2026/07/23) ♡
• A single-cell sequencing-based prognostic model reveals HLA-DRA, NPC2, and PRPF38B as immune-regulatory tumor suppressors in non-small cell lung cancer. (2026/07/23) ♡
• Systematic reviewiAll research on one question is searched according to fixed rules and compared side by side, so that no studies with poor outcomes are missed. Association between prognostic nutritional index and prognosis in non-small cell lung cancer patients receiving PD-1/PD-L1 inhibitors: a meta-analysis. (2026/07/23) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Redefining the concept of resectability in the landscape of perioperative treatments for lung cancer. (2026/07/22) ♡
• Clinicopathological correlations of perineural invasion in resected non-small cell lung cancer. (2026/07/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Case Report: Exceptional survival with immunotherapy in a patient with EGFR exon 20 insertion (p.S768_D770dup) and high PD-L1 expression. (2026/07/22) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cancer-associated fibroblasts in the lung cancer microenvironment from multi-dimensional mechanisms to therapeutic strategies. (2026/07/22) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Durable response to ALK inhibition in low-allele-frequency SPTBN1-ALK-rearranged gastric cancer followed by lineage plasticity-mediated resistance: a case report. (2026/07/21) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Intratumoral para-toluenesulfonamide as a tumor-ablative therapy for equine cutaneous tumors: a case series of three horses. (2026/07/21) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Perioperative Immunonutrition in Patients Undergoing Lung Cancer Surgery: Current Evidence and Future Perspectives. (2026/07/21) ♡
• Prognostic value of nutritional and inflammatory biomarkers in patients with non-small cell lung cancer and bone metastasis: A retrospective study. (2026/07/21) ♡
• Early tumor-informed circulating tumor DNA (ctDNA) dynamics correlate with response to first-line advanced NSCLC treated with pembrolizumab ± chemotherapy. (2026/07/21) ♡
• Lathyrol Targets G6PD to Disrupt Redox Homeostasis in Non-Small Cell Lung Cancer. (2026/07/20) ♡
• An integrated host vulnerability score is associated with survival in advanced NSCLC treated with nivolumab: a PET/CT-based real-world study. (2026/07/16) ♡
• Absolute risk of malignancy by treatment in patients with Crohn's disease compared to the general population: a nationwide population-based cohort study. (2026/07/16) ♡
• Incidence of Radiation Pneumonitis Following EGFR-TKI Combined With Thoracic Radiotherapy in Unresectable Stage III or IV Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis. (2026/07/16) ♡
• Experimental investigation and network pharmacology-based analysis of the anticancer mechanisms of Fei Jin Sheng formula. (2026/07/16) ♡
• Factors Associated with Postoperative Skeletal Muscle Loss during Hospitalization in Patients with Non-Small Cell Lung Cancer Undergoing Lobectomy: An Exploratory Retrospective Cohort Study. (2026/07/15) ♡
• The application value of serous cavity effusion supernatant in multi-driver gene detection for non-small cell lung cancer. (2026/07/15) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Clinical Study on the Prevention of High-Risk Pulmonary Nodule Progression With Yifei Sanjie Pill: Protocol for a Multicenter Randomized Controlled Trial. (2026/07/15) ♡
• Clinical phenotype identification based on inflammation-nutrition-coagulation biomarkers in advanced non-small cell lung cancer. (2026/07/15) ♡
• The impact of sarcopenia on short-term efficacy, toxic and adverse reactions, and prognosis in patients with non-small cell lung cancer undergoing concurrent chemoradiotherapy. (2026/07/14) ♡
• Holistic oncologic management improves quality of life in driver gene negative advanced NSCLC a latent growth curve modeling study. (2026/07/12) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Sing-a-Lung 2.0: protocol for a multicentre randomised controlled trial to investigate the effects and mechanisms of online-delivered singing training versus usual care 6-18 months after surgical resection for non-small cell lung cancer (NSCLC). (2026/07/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Triple-Component Lung Carcinoma Diagnosed After Nondiagnostic EBUS: A Case Report. (2026/07/10) ♡
• Circulating immune and biochemical markers predict tumor response to immunotherapy in advanced melanoma and lung cancer. (2026/07/09) ♡
• Shuyu Wan Potentiates PD-1 Inhibitor Efficacy in Non-Small Cell Lung Cancer: Integrated Bioinformatics and Experimental Evidence for Gut Microbiota-Tumor Immune Crosstalk. (2026/07/08) ♡
• The Association and Predictive Value of Nutritional and Inflammatory Biomarkers in Advanced Non-Small Cell Lung Cancer Response to Immune Checkpoint Inhibitors. (2026/07/08) ♡
• Correction: EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells. (2026/07/06) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Marantic Endocarditis Presenting With Ischemic Stroke in Advanced Non-small Cell Lung Cancer: The Contribution of Fluorodeoxyglucose (FDG) PET/CT to the Differential Diagnosis of Valvular Vegetations. (2026/07/06) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Combination of polygonatum sibiricum and hedyotis diffusa induces pyroptosis in non-small cell lung cancer cells via the TLR4/NLRP3/Caspase-1/GSDMD pathway: an in vitro and in vivo study using medicated serum and herbal extract. (2026/07/06) ♡
• Genome mining and metabolomics unveil new napyradiomycin antibiotics from Streptomyces sp. 0H2M. (2026/07/04) ♡
• Brief Report on Sociodemographic Patterns of Lung Cancer in Individuals Who Never Smoked. (2026/07/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Integrating chemokine signatures and multi-omic biomarkers to predict immunotherapy response in non-small cell lung cancer: a comprehensive narrative review. (2026/07/02) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Long-term efficacy of traditional Chinese medicine combined with chemotherapy for advanced non-small cell lung cancer: a systematic review and meta-analysis of reconstructed individual patient data over 3 years. (2026/07/02) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Advances in radiotherapy-based multimodal treatment for non-small-cell lung cancer. (2026/07/02) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.